1. European Regulatory Tools for Advanced Therapy Medicinal Products
2. Committee for Medicinal Products for Human Use European Medicines Agency.Alofisel® EPAR Public Assessment Report EMA/CHMP/64055/2018 Corr.1https://www.ema.europa.eu/en/documents/assessment‐report/alofisel‐epar‐public‐assessment‐report_en.pdf. Accessed May 13 2020.
3. Committee for Medicinal Products for Human Use European Medicines Agency.Yescarta® EPAR Public Assessment Report EMA/481168/2018.https://www.ema.europa.eu/en/documents/assessment‐report/yescarta‐epar‐public‐assessment‐report_en.pdf. Accessed May 13 2020.
4. Committee for Medicinal Products for Human Use European Medicines Agency.Kymriah® EPAR Public Assessment Report EMA/485563/2018.https://www.ema.europa.eu/en/documents/assessment‐report/kymriah‐epar‐public‐assessment‐report_en.pdf. Accessed May 13 2020.
5. Committee for Medicinal Products for Human Use European Medicines Agency.Zynteglo® EPAR Public Assessment Report. EMA/56140/2020/Corr.1https://www.ema.europa.eu/en/documents/assessment‐report/zynteglo‐epar‐public‐assessment‐report_en.pdf. Accessed May 13 2020.